Researchers were stunned this week by the loss of funding, which supported the search for better antivirals against COVID-19 ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

Annie Antar, MD, PhD, spoke about how long viral clearance could be an indicator of long COVID, but more research would need to be done to confirm this.

NEOS call for deeper cuts amid Austria’s widening deficit, vaccination gaps spark concern, and more news from Austria this ...

Whether during a routine doctor’s appointment, an emergency room trip or while dealing with unexpected diagnoses, too many ...

Thousands of Minnesotans remain exhausted and disabled after their COVID-19 illnesses, but why they got "long COVID" while ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look ...

I foolishly was in a crowded indoor location and got COVID (for the third time). I thought about getting Paxlovid. But I figured, heck, I’m healthy and vaccinated; I’ll just tough it out. This turned ...

I thought about getting Paxlovid. But I figured, heck, I’m healthy and vaccinated; I’ll just tough it out. This turned out to be a big mistake. I had three days of a super high fever.

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. “It still feels kind of incomplete,” said ...

The U.S. Government Patient Assistance Program (USG PAP), operated by Pfizer, will provide eligible Medicare beneficiaries with free Paxlovid access until December 31, 2025. This program is also ...